We are proud to share that we are sponsoring the ELRIG Innovation Award at Drug Discovery 2026, taking place in London, UK, from 14th to 15th October. Drug Discovery 2026 is Europe’s leading drug discovery and life sciences conference, offering attendees access to the most cutting-edge innovation and knowledge in the field.
The ELRIG Innovation Award is a celebration of the exciting new companies making tracks in drug discovery and development. The winner will gain the opportunity to present their innovation to an audience at the conference. In sponsoring the award, Mathys & Squire will be part of the judging panel and also provide winners with dedicated follow-on patent attorney support as a component of the prize.
The deadline to apply for the award is 28th August. To apply and learn more, click here.
In addition, we will be delivering a workshop focused on the importance of IP for attracting investment, as part of the event’s Breakthrough Zone.
About us
Mathys & Squire is a leading intellectual property firm with unrivalled expertise in patents, trade marks, design protection and litigation. The firm’s agile team of attorneys, scientists and strategists are steeped in experience, working with IP-rich and high-growth industries to leverage complex technologies and sophisticated commercial models. In particular, we have a dedicated life sciences group whose attorneys combine their knowledge of IP with a strong academic foundation in a varied range of areas, including small molecules, biologics, advanced therapeutics, antibodies, vaccines, drug delivery systems and diagnostics.
Preventing your competitors from taking advantage of your innovation is a crucial step for any business. Building a strong IP strategy will not only provide protection, but also vital fuel for commercial growth. At Mathys & Squire, we support you at every stage of the innovation cycle to maximise the potential of your IP and underpin the commercial success of your business.
About ELRIG
ELRIG is a not-for-profit organisation that brings together the global life science and drug discovery community through free-to-attend events. With a network of over 12,000 professionals, it is dedicated to promoting inclusion and accessibility whilst encouraging innovation across the sector.
To learn more about Drug Discovery 2026, click here.
